亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Controlled release tablets of verapamil hydrochloride

        2017-01-19 11:37:48TreephuKimlekTossapornPrasertpornJirametSawantranonChaisanSriwichupongGarnpimolRitthidej

        Treephu Kimlek,Tossaporn Prasertporn,Jiramet Sawantranon, Chaisan Sriwichupong,Garnpimol Ritthidej

        Pharmaceutical Technology Field,Department of Pharmaceutics and Industrial Pharmacy,Faculty of Pharmaceutical Sciences,Chulalongkorn University,Bangkok,Thailand

        Controlled release tablets of verapamil hydrochloride

        Treephu Kimlek*,Tossaporn Prasertporn,Jiramet Sawantranon, Chaisan Sriwichupong,Garnpimol Ritthidej

        Pharmaceutical Technology Field,Department of Pharmaceutics and Industrial Pharmacy,Faculty of Pharmaceutical Sciences,Chulalongkorn University,Bangkok,Thailand

        A R T I C L E I N F O

        Article history:

        Available online 24 November 2015

        Verapamil

        Controlled release

        HPMC

        Sodium alginate

        Verapamil is a calcium channel blocker drug which reduces heart rhythm and blood pressure in high blood pressure patient. The steady state of this drug has to be continually controlled to obtain optimal effcacy.In addition,patient compliance needs to be considered.Therefore,controlled release tablet of verapamil hydrochloride was essentially developed using hydrophilic matrix polymer,namely hydroxypropylmethyl cellulose(HPMC)and sodium alginate,and compared to marketed product[1].HPMC,a pH-independent polymer,hydrates to form a gel layer at the surface of the tablet to sustain the drug release.Sodium alginate,a pH-dependent gelling polymer, converts to insoluble alginic acid after exposure to acidic condition in stomach.The development of verapamil hydrochloride controlled release tablet was to vary the amount of HPMC and sodium alginate.Alteration of the type and quantity of excipients were included.Tablets were prepared by wet granulation method.Physical tests were evaluated on tablet such as appearance,thickness,hardness and weight variation.In dissolution test,USP monograph was followed using USP apparatus II(paddle).UV spectrophotometer was used to measure the amount of drug release[2],and then f1,f2 values were calculated.In assay study,high-pressure liquid chromatography was performed.

        The results showed that all formulations obviously passed the physical tests.The type and amount of polymer signifcantly affected the release of drug.For the effect of the variation in type and amount of rate controlling agents,change in amount of sodium alginate slightly affected the release of the drug while change in amount of HPMC had a great impact because the forming of gel layer at early stage(pH 1.2)created barrier to control the drug release whereas at buffer stage(pH 6.8),sodium alginate swelled and caused a synergistic control release effect (Fig.1a).For other excipients,decrease in the amount of microcrystalline cellulose,used as a disintegrant and magnesium stearate,used as a lubricant could reduce tablet disintegration.Finally,povidone K30 as a binder agent could increase granule compaction but with amount limitation.Formulation with accepted range of drug release in USP monograph was satisfactorily obtained and similar to the marketed product. This formulation contained 2.67%of HPMC and 11.33%of sodium alginate.The f1 and f2 values were 13.30 and 61.49,respectively(Fig.1b).

        Fig.1–Gel layer forming of tablet in acid and buffer condition.(a)Dissolution profle of the selected formulations prepared with small scale and large scale production:HPMC:Sodium alginate=2.67:11.33 compared to marketed product(b).

        Acknowledgement

        The authors acknowledge the fnancial support received from Thailand Center of Excellence for Life Sciences(TCELS).

        R E F E R E N C E S

        [1]Abbott Laboratories.Product Monograph:ISOPTIN?SR [monograph on the Internet],;2011.

        [2]The United States Pharmacopoeial Convention.USP36-NF31, vol.1.2013.p.5556–5563.

        [3]Qiu Y,Zhang G.Development of modifed-release solid oral dosage forms.In:Developing solid oral dosage forms: pharmaceutical theory and practice.2009.p.501–510.

        *E-mail address:tuarus_f@hotmail.com.

        Peer review under responsibility of Shenyang Pharmaceutical University.

        http://dx.doi.org/10.1016/j.ajps.2015.11.027

        1818-0876/?2016 Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).

        在线视频这里只有精品| 综合亚洲二区三区四区在线| 国产在线观看91一区二区三区| 亚洲妇熟xxxx妇色黄| 特黄a级毛片免费视频| 久久久久成人亚洲综合精品| 国产一区二区三区高清视频| 亚洲欧美日韩国产一区二区精品| 亚洲精品一区二区视频| 亚洲乱码av一区二区蜜桃av| 免费日本一区二区三区视频| 色777狠狠狠综合| 暖暖免费 高清 日本社区在线观看 | 国产区福利| 色青青女同性恋视频日本熟女 | 丰满少妇被粗大猛烈进人高清 | 高清毛茸茸的中国少妇| 日韩亚洲欧美中文在线| 伊伊人成亚洲综合人网7777 | 五月天婷婷综合网| 校花高潮一区日韩| 天堂丝袜美腿在线观看| 免费观看羞羞视频网站| 欧美日韩国产成人高清视| 九九99久久精品在免费线97| 中文字幕一区二区网址| 伊人久久大香线蕉av五月| 人妻无码一区二区视频| 国产精品video| 东京道一本热码加勒比小泽| 麻豆精品国产av在线网址| 97精品国产97久久久久久免费 | 日本精品a在线观看| 欧洲一级无码AV毛片免费| 99精品国产综合久久麻豆| 久久久中文久久久无码| 精品性影院一区二区三区内射| 久久亚洲精品国产精品婷婷| 国产综合精品久久99之一| 少妇无码av无码一区| 中文人妻无码一区二区三区|